Inventor · disambiguated record
Antonius Adrianus Hendrikus Petrus Megens
Also filed as: MEGENS ANTONIUS A H P · MEGENS ANTONIUS ADRIANUS H P · MEGENS ANTONIUS ADRIANUS HENDR · MEGENS ANTONIUS ADRIANUS HENDRIKUS
14 granted patents·6 pending applications·49 citations·filing 1998–2018
88Inventor score
Technology areasA61P
Files withJANSSEN PHARMACEUTICA NV10CID-NUNEZ JOSE MARIA3ANDRES-GIL JOSE IGNACIO1CID-NUNEZ JOSE M1FERNANDEZ-GADEA FRANCISCO JAVIER1
Top patents by PatentIndex Score
20 records- 0180US7915249B2Heterocyclic tetracyclic tetrahydrofuran derivatives as 5HT2 inhibitors in the treatment of CNS disordersJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Mar 29, 2011·4 cites·7 claims
- 0273US6235745B1Use of 5HT3, antagonists for promoting intestinal lavageJANSSEN PHARMACEUTICA NV·Filed 1998·Granted May 22, 2001·29 cites·12 claims
- 0371US7501418B2Fused heterocyclic isoxazoline derivatives and their use as anti-depressantsJANSSEN PHARMACEUTICA NV·Filed 2003·Granted Mar 10, 2009·6 cites·7 claims
- 0467US10106542B2Substituted 6,7-dihydropyrazolo[1,5-a]pyrazines as negative allosteric modulators of mGluR2 receptorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Oct 23, 2018·1 cites·25 claims
- 0567US7169786B2Isoxazoline derivatives as anti-depressantsANDRES-GIL JOSE IGNACIO·Filed 2002·Granted Jan 30, 2007·6 cites·16 claims
- 0665US8415347B2Substituted tetracyclic tetahydrofuran, pyrrolidine and tetrahydrothiophene derivativesCID-NUNEZ JOSE MARIA·Filed 2010·Granted Apr 9, 2013·1 cites·9 claims
- 0763US6555546B2Use of 5HT3 antagonists for promoting intestinal lavageJANSSEN PHARMACEUTICS N V·Filed 2001·Granted Apr 29, 2003·2 cites·4 claims
- 0854US8022102B2Unsaturated tetracyclic tetrahydrofuran derivativesJANSSEN PHARMACEUTICA NV·Filed 2005·Granted Sep 20, 2011·0 cites·5 claims
- 0953US2012238563A1Novel unsaturated tetracyclic tetrahydrofuran derivativesCID-NUNEZ JOSE MARIA·Filed 2012·Application pending·0 cites
- 1051US2012035170A1Novel unsaturated tetracyclic tetrahydrofuran derivativesNUNEZ JOSE MARIA·Filed 2011·Application pending·0 cites
- 1150US10584129B2Substituted 6,7-dihydropyrazolo[1,5-a]pyrazines as negative allosteric modulators of mGluR2 receptorsJANSSEN PHARMACEUTICA NV·Filed 2018·Granted Mar 10, 2020·0 cites·25 claims
- 1250US9669035B2Combinations comprising PDE 2 inhibitors such as 1-aryl-4-methyl-[1,2,4]triazolo-[4,3-A]]quinoxaline compounds and PDE 10 inhibitors for use in the treatment of neurological of metabolic disordersJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Jun 6, 2017·0 cites·2 claims
- 1347US8404729B2Heterocyclic tetracyclic tetrahydrofuran derivativesCID-NUNEZ JOSE MARIA·Filed 2011·Granted Mar 26, 2013·0 cites·5 claims
- 1444US2008214572A1Selected Tetracyclic Tetrahydrofuran Derivatives Containing a Cyclic Amine Side ChainFERNANDEZ-GADEA FRANCISCO JAVIER·Filed 2006·Application pending·0 cites
- 1543US7462717B2C6-and C9-substituted chromeno[4,3-c]isoxazoline derivatives and their use as anti-depressantsJANSSEN PHARMACEUTICA NV·Filed 2003·Granted Dec 9, 2008·0 cites·11 claims
- 1642US7465741B2C-substituted tricyclic isoxazoline derivatives and their use as anti-depressantsJANSSEN PHARMACEUTICA NV·Filed 2003·Granted Dec 16, 2008·0 cites·8 claims
- 1742US2007197525A1Novel tetracyclic tetrahydrofuran derivativesCID-NUNEZ JOSE M·Filed 2005·Application pending·0 cites
- 1839US7635696B2Isoxazoline-indole derivatives with an improved antipsychotic and anxiolytic activityJANSSEN PHARMACEUTICA NV·Filed 2005·Granted Dec 22, 2009·0 cites·9 claims
- 1939US2009023721A1Novel Substituted Tetracyclic Tetrahydrofuran, Pyrrolidine and Tetrahydrothiophene Derivatives and Their Use as a MedicamentMEGENS ANTONIUS ADRIANUS HENDR·Filed 2006·Application pending·0 cites
- 2038US2004096423A1Use of a triple combination comprising a 5ht3 antagonist, a 5ht4agonist and a laxative for promoting intestinal lavageFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Antonius Adrianus Hendrikus Petrus Megens files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →